Entry |
|
Name |
Hydralazine polistirex (USAN) |
Class |
Cardiovascular agent
DG03231 Antihypertensive
DG02046 Hydrazinophthalazine derivative
Metabolizing enzyme substrate
DG02928 NAT substrate
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
|
Remark |
Product (DG00261): | D01302<JP/US> |
|
Efficacy |
Antihypertensive |
Comment |
Hydrazinophthalazine derivative
|
Target |
|
Metabolism |
|
Interaction |
CYP inhibition: CYP2D6 [HSA: 1565]
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02DB Hydrazinophthalazine derivatives
C02DB02 Hydralazine
D04458 Hydralazine polistirex (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG03231 Antihypertensive
DG00261 Hydralazine
D04458 Hydralazine polistirex
DG02046 Hydrazinophthalazine derivative
DG00261 Hydralazine
D04458 Hydralazine polistirex
Metabolizing enzyme substrate
DG02928 NAT substrate
DG00261 Hydralazine
D04458 Hydralazine polistirex
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG00261 Hydralazine
D04458 Hydralazine polistirex
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
AOC3
D04458 Hydralazine polistirex (USAN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D04458
Drug groups [BR:br08330]
Cardiovascular agent
DG03231 Antihypertensive
DG00261 Hydralazine
DG02046 Hydrazinophthalazine derivative
DG00261 Hydralazine
Metabolizing enzyme substrate
DG02928 NAT substrate
DG00261 Hydralazine
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
DG00261 Hydralazine
|
Other DBs |
|
LinkDB |
|